Genetic Diversity of NS3 Protease From Brazilian HCV Isolates and Possible Implications for Therapy With Direct-Acting Antiviral Drugs

Memorias do Instituto Oswaldo Cruz - Brazil
doi 10.1590/s0074-02762012000200016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events

Gastroenterology
HepatologyGastroenterology
2019English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Gastroenterology
HepatologyGastroenterology
2019English

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

Frontiers in Medicine
Medicine
2019English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Hepatocellular Carcinoma Risk After Direct-Acting Antiviral Therapy

Clinical Liver Disease
Hepatology
2019English

Hepatocellular Carcinoma Mechanisms Associated With Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment

Journal of Hepatocellular Carcinoma
2020English

Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method to Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes From HCV Genotypes 1 to 6

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy